
---
title: '针对糖尿病并发症的小分子化合物！'
categories: 
 - 新媒体
 - 科学网
 - 博客
headimg: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202112/01/093549rjhj33wyph1j23ja.png'
author: 科学网
comments: false
date: Wed, 01 Dec 2021 09:35:00 GMT
thumbnail: 'https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202112/01/093549rjhj33wyph1j23ja.png'
---

<div>   
<p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><br></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">这是《科学转化医学》</span><span style="font-family:Calibri">2021</span><span style="font-family:宋体">年</span><span style="font-family:Calibri">12</span><span style="font-family:宋体">月上线的最新研究论文。</span></span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: 宋体;line-height: 200%;color: #0000FF;font-size: 16px">糖基化终末产物</span></strong><strong><span style="font-family: 宋体;line-height: 200%;color: #0000FF;font-size: 16px">是一种衰老相关分子，这种分子是导致人衰老的一种重要因素，也是糖尿病患者各种器官功能障碍的重要原因。阻断这类物质的受体实现阻断这种衰老分子的不利效应，不仅能预防和治疗糖尿病并发症，而且可能是一种抗衰老药物。关于这种小分子的抗衰老作用，希望能尽快看到相关临床研究结果。</span></strong></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">抑制晚期糖基化终末产物受体</span><span style="font-family:Calibri">(RAGE)</span><span style="font-family:宋体">已被证明可以减少糖尿病并发症。</span><span style="font-family:Calibri">Manigrasso</span><span style="font-family:宋体">等人没有针对</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">的胞外区域，而是开发了一种名为</span><span style="font-family:Calibri">RAGE229</span><span style="font-family:宋体">的小分子，它能够抑制</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">的细胞质尾部与</span><span style="font-family:Calibri">diaphanous1</span><span style="font-family:宋体">之间的相互作用，从而</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">可</span><strong><span style="font-family: 宋体;line-height: 200%;color: #0000FF;font-size: 16px"><span style="font-family:宋体">完全抑制细胞内</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">信号的传递。</span></span></strong><span style=";font-family:宋体;line-height:200%;font-size:16px">在小鼠模型中，</span><span style=";font-family:宋体;line-height:200%;font-size:16px">这种</span><span style=";font-family:宋体;line-height:200%;font-size:16px">小分子减少了糖尿病并发症，包括</span><strong><span style="font-family: 宋体;line-height: 200%;color: #0000FF;font-size: 16px">损伤愈合、缺血和通过减少糖尿病相关炎症引起的肾脏疾病</span></strong><span style=";font-family:宋体;line-height:200%;font-size:16px">。结果表明，</span><strong><span style="font-family: 宋体;line-height: 200%;color: #0000FF;font-size: 16px"><span style="font-family:宋体">靶向细胞内</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">区域可能是阻断病理性</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">信号通路的有效策略。</span></span></strong></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><strong><span style="font-family: 宋体;line-height: 200%;color: #0000FF;font-size: 16px"><span style="font-family:宋体"><img src="https://cors.zfour.workers.dev/?http://image.sciencenet.cn/home/202112/01/093549rjhj33wyph1j23ja.png" title alt="12974_2018_1284_Fig2_HTML.png" referrerpolicy="no-referrer"><br></span></span></strong></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px">糖尿病的大血管和微血管并发症</span><span style=";font-family:宋体;line-height:200%;font-size:16px">可</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">导致疾病严重程度和死亡率增加。晚期糖基化终末产物受体</span><span style="font-family:Calibri">(RAGE)</span><span style="font-family:宋体">结合</span><span style="font-family:Calibri">AGEs</span><span style="font-family:宋体">和多种促炎症配体。临床前研究表明</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">，</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">拮抗剂对糖尿病的许多并发症有有益的作用。</span></span><strong><span style="font-family: 宋体;line-height: 200%;color: #0000FF;font-size: 16px"><span style="font-family:宋体">然而，这些拮抗剂针对</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">的细胞外结构域，它们在免疫球蛋白样可变结构域和两个恒定结构域的不同位点结合不同的</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">配体。</span></span></strong><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">的细胞质尾</span><span style="font-family:Calibri">(ctRAGE)</span><span style="font-family:宋体">与</span><span style="font-family:Calibri">formin Diaphanous-1 (DIAPH1)</span><span style="font-family:宋体">结合，这种相互作用对</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">信号传导很重要。为了全面捕捉</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">信号通路的广度，我们开发了</span><span style="font-family:Calibri">ctRAGE-DIAPH1</span><span style="font-family:宋体">相互作用的小分子拮抗剂，称为</span><span style="font-family:Calibri">RAGE229</span><span style="font-family:宋体">。我们证明了</span><span style="font-family:Calibri">RAGE229</span><span style="font-family:宋体">在抑制</span><span style="font-family:Calibri">RAGE-DIAPH1</span><span style="font-family:宋体">结合、</span><span style="font-family:Calibri">Förster</span><span style="font-family:宋体">共振能量转移和细胞检测中的生物活性方面是有效的。利用溶液核磁共振波谱技术，我们确定了</span><span style="font-family:Calibri">RAGE229</span><span style="font-family:宋体">与</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">相互作用的分子基础。在体内实验中，我们发现</span><span style="font-family:Calibri">RAGE229</span><span style="font-family:宋体">能在不降低血糖浓度的情况下减轻雄性和雌性小鼠的短期和长期糖尿病并发症。最后，</span><span style="font-family:Calibri">RAGE229</span><span style="font-family:宋体">降低了糖尿病小鼠血浆中</span><span style="font-family:Calibri">TNF-</span><span style="font-family:宋体">α、</span><span style="font-family:Calibri">IL-6</span><span style="font-family:宋体">和</span><span style="font-family:Calibri">CCL2/JE-MCP1</span><span style="font-family:宋体">的浓度，同时降低了糖尿病样肾脏疾病的病理和功能指标。靶向</span><span style="font-family:Calibri">ctRAGE-DIAPH1</span><span style="font-family:宋体">与</span><span style="font-family:Calibri">RAGE229</span><span style="font-family:宋体">的相互作用可通过减弱炎症信号通路减轻啮齿动物的糖尿病并发症。</span></span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">晚期糖基化终末产物受体</span><span style="font-family:Calibri">(RAGE)</span><span style="font-family:宋体">是免疫球蛋白超家族的一员，与多种配体结合并转导信号。</span><span style="font-family:Calibri">AGER</span><span style="font-family:宋体">编码的</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">蛋白由</span><span style="font-family:Calibri">3</span><span style="font-family:宋体">个胞外结构域组成</span><span style="font-family:Calibri">:1</span><span style="font-family:宋体">个</span><span style="font-family:Calibri">ig</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px"> </span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:Calibri">(V)</span><span style="font-family:宋体">型结构域，</span><span style="font-family:Calibri">2</span><span style="font-family:宋体">个</span><span style="font-family:Calibri">ig (C)</span><span style="font-family:宋体">型结构域，分别命名为</span><span style="font-family:Calibri">C1</span><span style="font-family:宋体">和</span><span style="font-family:Calibri">C2;</span><span style="font-family:宋体">单个跨膜结构域</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">，</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">和一个短的，高电荷的细胞质尾部</span><span style="font-family:Calibri">(ct)</span><span style="font-family:宋体">区域或</span><span style="font-family:Calibri">ctRAGE</span><span style="font-family:宋体">。该受体因其配体家族，晚期糖基化终末产物</span><span style="font-family:Calibri">(AGEs)</span><span style="font-family:宋体">而得名，</span></span><strong><span style="font-family: 宋体;line-height: 200%;color: #0000FF;font-size: 16px"><span style="font-family:Calibri">AGEs</span><span style="font-family:宋体">在肥胖、糖尿病、衰老、氧化和炎症应激中积累</span></span></strong><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">。</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">也是</span><span style="font-family:Calibri">S100/</span><span style="font-family:宋体">钙粒蛋白</span><span style="font-family:Calibri">(</span><span style="font-family:宋体">如</span><span style="font-family:Calibri">S100A12</span><span style="font-family:宋体">和</span><span style="font-family:Calibri">S100B)</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">、</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:Calibri">HMGB1</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">、</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">淀粉样</span><span style="font-family:宋体">β蛋白肽</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">、</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">磷脂酰丝氨酸</span><span style="font-family:Calibri">(PS)</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">、</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">溶血磷脂酸</span><span style="font-family:Calibri">(LPA)</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">的受体</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">。早前已经表明</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">配体结合在</span><span style="font-family:Calibri">v</span><span style="font-family:宋体">型结构域</span><span style="font-family:Calibri">(</span><span style="font-family:宋体">和</span><span style="font-family:Calibri">/</span><span style="font-family:宋体">或</span><span style="font-family:Calibri">V-C1</span><span style="font-family:宋体">结构域</span><span style="font-family:Calibri">)</span><span style="font-family:宋体">上，但大量研究表明，某些</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">配体可能结合在</span><span style="font-family:Calibri">C1-</span><span style="font-family:宋体">和</span><span style="font-family:Calibri">c2</span><span style="font-family:宋体">型细胞外结构域上，而不涉及</span><span style="font-family:Calibri">v</span><span style="font-family:宋体">型结构域的连接。</span></span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">鉴于</span><span style="font-family:Calibri">ctRAGE</span><span style="font-family:宋体">是</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">配体刺激信号通路所必需的证据，探究该区域通过信号转导级联来调节基因表达和细胞特性的机制是合乎逻辑的。为此，一个酵母双杂交实验，用于发现</span><span style="font-family:Calibri">ctRAGE</span><span style="font-family:宋体">结合分子，鉴定</span><span style="font-family:Calibri">Diaphanous-1 (DIAPH1)</span><span style="font-family:宋体">作为一个假定的相互作用伙伴。免疫沉淀实验证实了这种相互作用，并鉴定出</span><span style="font-family:Calibri">ctRAGE</span><span style="font-family:宋体">与</span><span style="font-family:Calibri">DIAPH1</span><span style="font-family:宋体">的</span><span style="font-family:Calibri">formin homology 1 (FH1)</span><span style="font-family:宋体">结构域结合</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">。</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">通过沉默</span><span style="font-family:Calibri">RNA</span><span style="font-family:宋体">方法降低培养细胞中</span><span style="font-family:Calibri">Diaph1</span><span style="font-family:宋体">的表达，阻断</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">配体介导的多种信号通路的激活。</span><span style="font-family:Calibri">RAGE</span><span style="font-family:宋体">和</span><span style="font-family:Calibri">DIAPH1</span><span style="font-family:宋体">在人类和小鼠糖尿病肾病中都有高表达，最近研究表明，在血管损伤、心脏缺血和糖尿病相关性肾病的小鼠模型中，体内缺失</span><span style="font-family:Calibri">DIAPH1</span><span style="font-family:宋体">与缺失</span><span style="font-family:Calibri">Ager</span><span style="font-family:宋体">具有类似的益处。</span></span></p><p style="margin-top:4px;margin-right:0;margin-bottom:4px;margin-left:0;text-indent:28px;padding:0 0 0 0 ;text-autospace:ideograph-numeric;text-align:justify;text-justify:inter-ideograph;line-height:200%;background:rgb(247,248,250)"><span style="font-family: Tahoma;color: #333333;letter-spacing: 0;font-size: 16px"><span style="font-family:Tahoma">先前筛选了</span>58,000个已知小分子文库，并鉴定出13个与DIAPH1相互作用的ctRAGE竞争性小分子抑制剂;这些分子减少RAGE配体介导的信号传导，并在体内抑制RAGE配体的急性炎症效应。目前的研究中，对这13种已鉴定的拮抗剂的特性进行严格审查的基础上，我们的目标是优化其中一类筛选物(2-苯基喹啉支架)的结构-活性关系(SARs)，用于在糖尿病并发症的小鼠模型中进行测试。我们报道发现了RAGE229, N-(4-(7-氰基-4-(4-甲基)喹啉-2-基)苯基)乙酰胺，作为一种ctRAGE-DIAPH1抑制剂。与载体对照相比，RAGE229阻断了ctRAGE-DIAPH1的相互作用，减少了1型和/或2型糖尿病小鼠炎症、缺血和长期糖尿病的后果，在心脏缺血、伤口愈合和糖尿病相关肾病的体内模型中进行了测试。总的来说，这项工作确定了一种ctRAGE-DIAPH1相互作用的有效拮抗剂，并确定了一种针对RAGE病理激活在慢性疾病(如糖尿病并发症)中后果的潜在方法。</span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">据研究，血糖浓度升高直接导致人类受试者的糖尿病并发症，在这些研究中，严格的高血糖管理和强化降糖策略可以减少</span><span style="font-family:Calibri">1</span><span style="font-family:宋体">型和</span><span style="font-family:Calibri">2</span><span style="font-family:宋体">型糖尿病的长期并发症。最近研究表明，抗糖尿病药物，如胰高血糖素样肽</span><span style="font-family:Calibri">1 (GLP-1)</span><span style="font-family:宋体">激动剂、二肽基肽酶</span><span style="font-family:Calibri">4 (DPP4)</span><span style="font-family:宋体">抑制剂和钠葡萄糖共转运蛋白</span><span style="font-family:Calibri">2 (SGLT2)</span><span style="font-family:宋体">抑制剂，对高血糖以及心血管和肾脏后遗症有不同程度的影响。其中一些药物引起了并发症，如酮症酸中毒、胃肠道不适、糖尿病视网膜病变恶化以及泌尿系统和其他感染。由于这些药物主要被推荐给</span><span style="font-family:Calibri">2</span><span style="font-family:宋体">型糖尿病患者而不是</span><span style="font-family:Calibri">1</span><span style="font-family:宋体">型糖尿病患者，</span></span><strong><span style="font-family: 宋体;line-height: 200%;color: #0000FF;font-size: 16px"><span style="font-family:宋体">它们在治疗糖尿病并发症方面的普遍性不足可能限制了</span><span style="font-family:Calibri">1</span><span style="font-family:宋体">型糖尿病患者的任何潜在好处</span></span></strong><span style=";font-family:宋体;line-height:200%;font-size:16px">。因此，</span><strong><span style="font-family: 宋体;line-height: 200%;color: #0000FF;font-size: 16px">糖尿病并发症的治疗仍然存在空白。</span></strong></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">本研究表明，小分子拮抗</span><span style="font-family:Calibri">ctRAGE-DIAPH1</span><span style="font-family:宋体">与</span><span style="font-family:Calibri">RAGE229</span><span style="font-family:宋体">相互作用的好处</span></span><strong><span style="font-family: 宋体;line-height: 200%;color: #0000FF;font-size: 16px">并不依赖于降糖作用</span></strong><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">。在这些研究中注意到的唯一差异是在用于含</span><span style="font-family:Calibri">rage</span><span style="font-family:宋体">的</span><span style="font-family:Calibri">chow</span><span style="font-family:宋体">肾病研究的雄性</span><span style="font-family:Calibri">BTBR ob/ob</span><span style="font-family:宋体">小鼠中观察到的。在那个实验模型中，</span><span style="font-family:Calibri">rage229</span><span style="font-family:宋体">治疗的雄性小鼠的血糖浓度高于治疗的雌性小鼠，而不是雌性小鼠。先前的数据报道，</span><span style="font-family:Calibri">ob/ob</span><span style="font-family:宋体">小鼠在出生时与它们的瘦弱同伴无法区分，但在</span><span style="font-family:Calibri">2</span><span style="font-family:宋体">周内，它们变得更重并出现高胰岛素血症，在生命的第四周出现明显的高血糖</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">。</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">血糖浓度已显示上升，并在</span><span style="font-family:Calibri">3</span><span style="font-family:宋体">至</span><span style="font-family:Calibri">5</span><span style="font-family:宋体">个月大时达到峰值</span><span style="font-family:Calibri">;</span><span style="font-family:宋体">在那之后，这些浓度就会下降，最终在年老的动物体内接近正常水平。</span></span><strong><span style="font-family: 宋体;line-height: 200%;color: #0000FF;font-size: 16px"><span style="font-family:宋体">因此，我们推测</span><span style="font-family:Calibri">RAGE229</span><span style="font-family:宋体">改善了小鼠的整体健康状况，并阻止了与衰老相关的血糖浓度下降</span></span></strong><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">。至关重要的是要注意</span><span style="font-family:Calibri">,</span><span style="font-family:宋体">在</span><span style="font-family:Calibri">C57BL / 6 1</span><span style="font-family:宋体">型糖尿病模型中</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">，</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:Calibri">RAGE229</span><span style="font-family:宋体">施加不影响血糖浓度</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">，</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">和</span><span style="font-family:Calibri">BTBR ob / ob</span><span style="font-family:宋体">老鼠受到伤口愈合和</span><span style="font-family:Calibri">RAGE229,</span><span style="font-family:宋体">观察血糖没有差异</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">，</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">可能因为这些老鼠小于</span><span style="font-family:Calibri">6</span><span style="font-family:宋体">个月的时候安乐死</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">，</span><span style=";font-family:宋体;line-height:200%;font-size:16px"><span style="font-family:宋体">因此</span><span style="font-family:Calibri">BTBR ob/ob</span><span style="font-family:宋体">小鼠尚未</span></span><span style=";font-family:宋体;line-height:200%;font-size:16px">发生</span><span style=";font-family:宋体;line-height:200%;font-size:16px">衰老相关的</span><span style=";font-family:宋体;line-height:200%;font-size:16px">改变</span><span style=";font-family:宋体;line-height:200%;font-size:16px">。</span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px">更详细内容</span></p><p style="margin-left:0;text-indent:28px;text-autospace:ideograph-numeric;line-height:200%"><span style=";font-family:宋体;line-height:200%;font-size:16px"><a href="https://www.science.org/doi/10.1126/scitranslmed.abf7084" target="_blank">Small-molecule antagonism of the interaction of the RAGE cytoplasmic domain with DIAPH1 reduces diabetic complications in mice (science.org)</a><br></span></p><p><br></p>                    <br><br>
                                        <label style="font-size:13px; color:#850f0f">转载本文请联系原作者获取授权，同时请注明本文来自孙学军科学网博客。<br>链接地址：</label><a href="http://blog.sciencenet.cn/blog-41174-1314628.html" target="_blank" style="font-size:13px; color:#850f0f">http://blog.sciencenet.cn/blog-41174-1314628.html </a>
  <br><br>上一篇：<a href="http://blog.sciencenet.cn/blog-41174-1311964.html" target="_black">《科学》水分子催化在雾霾成分化学反应具有关键作用</a><br>                    <!--大赛结束-->
                                        
  
</div>
            